Drew Yonchak

Drew Yonchak is a shareholder in the Memphis office of Baker Donelson and a member of the Firm’s Corporate Finance and Securities Group. Mr. Yonchak’s practice primarily includes the representation of buyers and sellers in public and private mergers, acquisitions, dispositions and joint ventures across a wide range of industries, including the manufacturing, retail, food and technology industries.

Mr. Yonchak also has significant experience representing public companies with general corporate governance and securities compliance matters, including SEC periodic reporting, proxy statement design and proxy solicitations, Section 16 reporting, and NYSE and NASDAQ listing qualifications compliance.

EDUCATION:

• University of Georgia School of Law, J.D., 2009, cum laude
• University of Georgia, B.A., 2005, magna cum laude

ADMISSIONS:

• Tennessee, 2014
• North Carolina, 2009

Representative Matters:

• Corporate Governance and Securities Regulation
  • Regularly counsels public companies on ’34 Act reporting compliance and stock exchange listing qualifications.
  • Regularly counsels public companies on current trends for proxy season, proxy statement design and how to improve shareholder engagement.
  • Regularly counsels public and private companies on all types of governance policies, procedures, and activities, including special board committee matters.
  • Prepared a definitive merger proxy statement in connection with the $1.4 billion sale of a public, non-traded REIT.
  • Represented a public company in connection with an inquiry by FINRA into unusual patterns of trading in advance of a significant public announcement.
• Mergers and Acquisitions
  • Represented a NASDAQ-listed technology company with its strategic acquisition of a supply chain software analytics company.
  • Represented a private contract food manufacturer in multiple strategic acquisitions.
  • Multiple add-on acquisitions by a private prepared foods service company, followed by the divestiture of the company through an auction process.
  • Represented a specialty veterinary hospital and emergency veterinary clinic in its sale to a national veterinary network.
• Securities Offerings
  • Issuance of $75 million of subordinated notes by a NASDAQ-listed financial institution.
  • Shelf registration of $300 million of securities by a NASDAQ-listed diversified industrial manufacturer.
  • Issuance of $300 million registered senior notes by a NYSE-listed sports and entertainment company.
  • Issuance of $150 million senior notes by a NYSE-listed sports and entertainment company.
  • Issuance of $130 million of common stock by a NYSE-listed energy company, which included the forward sale of common stock.